Richard A. Rudick

35.4k total citations · 10 hit papers
214 papers, 21.7k citations indexed

About

Richard A. Rudick is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Richard A. Rudick has authored 214 papers receiving a total of 21.7k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Pathology and Forensic Medicine, 53 papers in Neurology and 51 papers in Oncology. Recurrent topics in Richard A. Rudick's work include Multiple Sclerosis Research Studies (159 papers), Peripheral Neuropathies and Disorders (37 papers) and Polyomavirus and related diseases (29 papers). Richard A. Rudick is often cited by papers focused on Multiple Sclerosis Research Studies (159 papers), Peripheral Neuropathies and Disorders (37 papers) and Polyomavirus and related diseases (29 papers). Richard A. Rudick collaborates with scholars based in United States, Switzerland and Netherlands. Richard A. Rudick's co-authors include Bruce D. Trapp, Richard M. Ransohoff, Elizabeth Fisher, John W. Peterson, Sverre Mørk, Lars Bø, Gary Cutter, Jill S. Fischer, Jack H. Simon and Ansi Chang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Richard A. Rudick

213 papers receiving 21.0k citations

Hit Papers

Axonal Transection in the... 1998 2026 2007 2016 1998 2006 1999 2002 2006 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Axonal Transection in the Lesions of Multiple Sclerosis
    1998 3.1k citations Richard A. Rudick et al. profile →
  2. Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
    2006 982 citations Richard A. Rudick, William H. Stuart et al. profile →
  3. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment
    1999 809 citations Richard A. Rudick, Gary Cutter et al. Multiple Sclerosis Journal profile →
  4. Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
    2002 770 citations Richard A. Rudick et al. profile →
  5. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
    2006 647 citations Richard A. Rudick et al. profile →
  6. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
    2017 607 citations Richard A. Rudick et al. Multiple Sclerosis Journal profile →
  7. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
    1999 578 citations Richard A. Rudick, Elizabeth Fisher et al. Neurology profile →
  8. Gray matter atrophy in multiple sclerosis: A longitudinal study
    2008 491 citations Elizabeth Fisher, Kunio Nakamura et al. profile →
  9. The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
    2017 344 citations Richard A. Rudick et al. Multiple Sclerosis Journal profile →
  10. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
    2017 302 citations Robert W. Motl, Jeffrey A. Cohen et al. Multiple Sclerosis Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard A. Rudick United States 71 16.0k 5.5k 4.1k 3.4k 3.2k 214 21.7k
Jeffrey A. Cohen United States 69 13.2k 0.8× 5.6k 1.0× 3.2k 0.8× 3.1k 0.9× 4.1k 1.3× 314 22.7k
Per Soelberg Sørensen Denmark 73 13.2k 0.8× 5.7k 1.0× 3.4k 0.8× 3.8k 1.1× 2.5k 0.8× 447 21.8k
Bianca Weinstock‐Guttman United States 75 15.3k 1.0× 5.7k 1.0× 3.5k 0.8× 2.4k 0.7× 2.5k 0.8× 518 20.5k
Stephen C. Reingold United States 33 21.4k 1.3× 7.3k 1.3× 5.7k 1.4× 3.2k 0.9× 2.9k 0.9× 56 26.0k
Paul O’Connor Canada 52 19.7k 1.2× 6.9k 1.2× 4.8k 1.2× 5.1k 1.5× 3.4k 1.1× 152 25.1k
Moses Rodriguez United States 79 13.7k 0.9× 6.1k 1.1× 3.0k 0.7× 2.9k 0.8× 5.4k 1.7× 489 27.0k
Jerry S. Wolinsky United States 58 23.4k 1.5× 8.6k 1.6× 6.5k 1.6× 4.0k 1.2× 3.3k 1.0× 243 28.5k
Michael Hutchinson Ireland 54 13.9k 0.9× 6.6k 1.2× 3.6k 0.9× 3.6k 1.1× 2.5k 0.8× 295 21.8k
Gavin Giovannoni United Kingdom 79 14.1k 0.9× 7.2k 1.3× 3.2k 0.8× 4.4k 1.3× 4.3k 1.4× 678 26.2k
Eva Havrdová Czechia 57 18.7k 1.2× 6.2k 1.1× 4.8k 1.2× 5.2k 1.5× 3.1k 1.0× 385 23.5k

Countries citing papers authored by Richard A. Rudick

Since Specialization
Citations

This map shows the geographic impact of Richard A. Rudick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Rudick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Rudick more than expected).

Fields of papers citing papers by Richard A. Rudick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Rudick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Rudick. The network helps show where Richard A. Rudick may publish in the future.

Co-authorship network of co-authors of Richard A. Rudick

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Rudick. A scholar is included among the top collaborators of Richard A. Rudick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Rudick. Richard A. Rudick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cutter, Gary, Richard A. Rudick, Carl de Moor, et al.. (2023). Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(2). 3100532663–3100532663. 7 indexed citations
2.
3.
Rao, Stephen M., Lyla Mourany, David Schindler, et al.. (2017). Processing speed test: Validation of a self-administered, iPad ® -based tool for screening cognitive dysfunction in a clinic setting. Multiple Sclerosis Journal. 23(14). 1929–1937. 117 indexed citations
4.
Mellion, Michelle, Keith R. Edwards, Raymond Hupperts, et al.. (2017). Additional Efficacy Analyses from the Phase 2b SYNERGY Study Investigating the Anti-LINGO-1 Monoclonal Antibody Opicinumab for Treatment of Disabling Multiple Sclerosis (P5.337). Neurology. 88(16_supplement). 1 indexed citations
5.
Nakamura, Kunio, Stephen E. Jones, Wim Van Hecke, et al.. (2017). Comparison of Brain Atrophy Measurement Techniques in a Longitudinal Study of Multiple Sclerosis Patients with Frequent MRIs (P4.376). Neurology. 88(16_supplement). 3 indexed citations
6.
Nakamura, Kunio, A Deshmane, Yun Jiang, et al.. (2016). A Novel Method for Quantification of Normal Appearing Brain Tissue in Multiple Sclerosis: Magnetic Resonance Fingerprinting (P4.158). Neurology. 86(16_supplement). 5 indexed citations
7.
Rudick, Richard A., Deborah Miller, François Béthoux, et al.. (2014). The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool. Journal of Visualized Experiments. e51318–e51318. 86 indexed citations
8.
Rudick, Richard A., François Béthoux, Stephen M. Rao, et al.. (2014). The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool. Journal of Visualized Experiments. 23 indexed citations
9.
Fisher, Elizabeth, et al.. (2012). Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic. JAMA Neurology. 70(3). 338–338. 67 indexed citations
10.
Goldman, Myla, Robert W. Motl, & Richard A. Rudick. (2010). Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 3(4). 229–239. 116 indexed citations
11.
Rudick, Richard A., Jar-Chi Lee, Gary Cutter, et al.. (2010). Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis. Archives of Neurology. 67(11). 1329–35. 55 indexed citations
12.
Radüe, Ernst-Wilhelm, William H. Stuart, Peter A. Calabresi, et al.. (2010). Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the Neurological Sciences. 292(1-2). 28–35. 43 indexed citations
13.
Weinstock‐Guttman, Bianca, Monika Baier, Youngmin Park, et al.. (2005). Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukotrienes and Essential Fatty Acids. 73(5). 397–404. 148 indexed citations
14.
Pelfrey, Clara M., Richard A. Rudick, Anne Cotleur, et al.. (2000). Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production. The Journal of Immunology. 165(3). 1641–1651. 106 indexed citations
15.
Goodkin, Donald E. & Richard A. Rudick. (1996). Multiple sclerosis : advances in clinical trial design, treatment, and future perspectives. Springer eBooks. 16 indexed citations
16.
Whiting, Donald, Melinda L. Estes, Cathy Sila, et al.. (1992). Stereotactic biopsy of non-neoplastic lesions in adults. Cleveland Clinic Journal of Medicine. 59(1). 48–55. 18 indexed citations
17.
Ransohoff, Richard M., Vincent K. Tuohy, Barbara P. Barna, & Richard A. Rudick. (1992). Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo. Journal of Neuroimmunology. 37(3). 169–176. 19 indexed citations
18.
Rudick, Richard A.. (1992). Cytokine Secretion by Multiple Sclerosis Monocytes. Archives of Neurology. 49(3). 265–265. 66 indexed citations
19.
Ross, Jeffrey S., et al.. (1992). Volume T1-Weighted Gradient Echo MRI in Multiple Sclerosis Patients. Journal of Computer Assisted Tomography. 16(5). 731–736. 13 indexed citations
20.
Smith, Alison S., David M. Meisler, Meredith A. Weinstein, et al.. (1989). High-Signal Periventricular Lesions in Patients with Sarcoidosis: Neurosarcoidosis or Multiple Sclerosis?. American Journal of Neuroradiology. 10(3). 485–490. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Cohen Breakdown of academic impact, for papers by Per Soelberg Sørensen Breakdown of academic impact, for papers by Bianca Weinstock‐Guttman Breakdown of academic impact, for papers by Stephen C. Reingold Breakdown of academic impact, for papers by Paul O’Connor Breakdown of academic impact, for papers by Moses Rodriguez Breakdown of academic impact, for papers by Jerry S. Wolinsky Breakdown of academic impact, for papers by Michael Hutchinson Breakdown of academic impact, for papers by Gavin Giovannoni Breakdown of academic impact, for papers by Eva Havrdová
Rankless by CCL
2026